{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:45:46Z","timestamp":1782863146581,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["Grant# 31479"],"award-info":[{"award-number":["Grant# 31479"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12228-5","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:47:15Z","timestamp":1782859635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effects of netarsudil ophthalmic solution on the expression of genes involved in fibrogenesis in orbital fibroblasts of patients with thyroid eye disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Fatemeh","family":"Sanie-Jahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Armaghanifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"12228_CR1","unstructured":"Gibson A, Kothapudi VN, Czyz CN (2022) Graves disease orbital decompression. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470345\/"},{"issue":"6","key":"12228_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063288","volume":"25","author":"H-I Chiu","year":"2024","unstructured":"Chiu H-I, Wu S-B, Tsai C-C (2024) The role of fibrogenesis and extracellular matrix proteins in the pathogenesis of Graves\u2019 ophthalmopathy. Int J Mol Sci 25(6):3288","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12228_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archopht.120.3.380","volume":"120","author":"M Kazim","year":"2002","unstructured":"Kazim M, Goldberg RA, Smith TJ (2002) Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol 120(3):380\u2013386","journal-title":"Arch Ophthalmol"},{"key":"12228_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.849480","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu Y, Liu M, Gong Q, Shi A, Li X, Bai X, Guan X, Hao B, Liu F (2022) PD-L1 inhibits T cell-induced cytokines and hyaluronan expression via the CD40-CD40L pathway in orbital fibroblasts from patients with thyroid associated ophthalmopathy. Front Immunol 13:849480","journal-title":"Front Immunol"},{"key":"12228_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","volume":"142","author":"WA Dik","year":"2016","unstructured":"Dik WA, Virakul S, van Steensel L (2016) Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves\u2019 ophthalmopathy. Exp Eye Res 142:83\u201391","journal-title":"Exp Eye Res"},{"issue":"4","key":"12228_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","volume":"42","author":"M Marin\u00f2","year":"2019","unstructured":"Marin\u00f2 M, Rotondo Dottore G, Ionni I, Lanzolla G, Sabini E, Ricci D, Sframeli A, Mazzi B, Menconi F, Latrofa F (2019) Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves\u2019 disease and Graves\u2019 orbitopathy. J Endocrinol Invest 42(4):471\u2013480","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"12228_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/01676831003668443","volume":"29","author":"L van Steensel","year":"2010","unstructured":"van Steensel L, Dik WA (2010) The orbital fibroblast: a key player and target for therapy in graves\u2019 ophthalmopathy. Orbit (Amst) 29(4):202\u2013206","journal-title":"Orbit (Amst)"},{"key":"12228_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.exer.2016.07.001","volume":"149","author":"A Futakuchi","year":"2016","unstructured":"Futakuchi A, Inoue T, Fujimoto T, Inoue-Mochita M, Kawai M, Tanihara H (2016) The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts. Exp Eye Res 149:107\u2013115","journal-title":"Exp Eye Res"},{"key":"12228_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cbf.3382","volume":"37","author":"DG Ibrahim","year":"2019","unstructured":"Ibrahim DG, Ko JA, Iwata W, Okumichi H, Kiuchi Y (2019) An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor. Cell Biochem Funct 37:113\u2013124","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"12228_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00005-007-0009-7","volume":"55","author":"J Shi","year":"2007","unstructured":"Shi J, Wei L (2007) Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp (Warsz) 55(2):61\u201375","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"12228_CR11","doi-asserted-by":"crossref","unstructured":"Zhao S, Shi S, Yang W, Wang H, Jian T, He Q, Liu Y, Huang X, Wu T (2022) RhoA with associated trab or FT3 in the diagnosis and prediction of Graves\u2019 ophthalmopathy. Dis Markers 2022:8323946","DOI":"10.1155\/2022\/8323946"},{"issue":"1","key":"12228_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/clinem\/dgaf299","volume":"111","author":"Y Hai","year":"2026","unstructured":"Hai Y, Ma Q, Fang S, Bahramimehr F, Song C, Duan Y, Yu G, Lu X, Jin C, Wang X (2026) High-throughput proteomics and immunohistochemistry of orbital connective tissue in graves\u2019 orbitopathy. J Clin Endocrinol Metab 111(1):199\u2013208","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"12228_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1124\/pr.115.010595","volume":"67","author":"G Loirand","year":"2015","unstructured":"Loirand G (2015) Rho kinases in health and disease: from basic science to translational research. Pharmacol Rev 67(4):1074\u20131095","journal-title":"Pharmacol Rev"},{"issue":"3","key":"12228_CR14","first-page":"101","volume":"7","author":"M Moshirfar","year":"2018","unstructured":"Moshirfar M, Parker L, Birdsong OC, Ronquillo YC, Hofstedt D, Shah TJ, Gomez AT, Hoopes PCS (2018) Use of Rho kinase inhibitors in ophthalmology: a review of the literature. Medical Hypothesis. Med Hypothesis Discov Innov Ophthalmol 7(3):101\u2013111","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"11","key":"12228_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","volume":"125","author":"AP Tanna","year":"2018","unstructured":"Tanna AP, Johnson M (2018) Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology 125(11):1741\u20131756","journal-title":"Ophthalmology"},{"key":"12228_CR16","doi-asserted-by":"crossref","unstructured":"Sanie-Jahromi F, Sahraeian R, Khademi B (2026) Nanoperlite particles enhance fibrogenesis in thyroid orbital fibroblasts: a potential activated cell source for ocular tissue engineering. Biomed Res Int 2026:1795961","DOI":"10.1155\/bmri\/1795961"},{"key":"12228_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13104-025-07419-5","volume":"18","author":"F Sanie-Jahromi","year":"2025","unstructured":"Sanie-Jahromi F, Khademi B, Owji N (2025) Effect of enalapril and losartan on the expression of genes involved in inflammation, fibrogenesis, and apoptosis in orbital fibroblasts of graves\u2019 ophthalmopathy. BMC Res Notes 18:454","journal-title":"BMC Res Notes"},{"issue":"8","key":"12228_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362(8):726\u2013738","journal-title":"N Engl J Med"},{"issue":"16","key":"12228_CR19","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L (2016) Graves\u2019 disease. N Engl J Med 375(16):1552\u20131565","journal-title":"N Engl J Med"},{"key":"12228_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s43556-024-00216-9","volume":"5","author":"S Shan","year":"2024","unstructured":"Shan S, Su M, Wang H, Guo F, Li Y, Zhou Y, Liu H, Du L, Zhang J, Qiu J (2024) Y-27632 targeting ROCK1&2 modulates cell growth, fibrosis and epithelial-mesenchymal transition in hyperplastic prostate by inhibiting \u03b2-catenin pathway. Mol Biomed 5:52","journal-title":"Mol Biomed"},{"key":"12228_CR21","doi-asserted-by":"publisher","DOI":"10.31083\/fbl46605","author":"X Yin","year":"2026","unstructured":"Yin X, Hao Y, Ma Z, Xie Y, Bao B, Wei H, Wu Q, Li T, Hao J, Zhang X (2026) TGF-\u03b2\/RhoA\/ROCK signaling activation orchestrates ciliary body EMT and fibrosis in myopia. Frontiers in Bioscience-Landmark. https:\/\/doi.org\/10.31083\/fbl46605","journal-title":"Frontiers in Bioscience-Landmark"},{"issue":"3","key":"12228_CR22","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ (2014) Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55(3):1735\u20131748","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"12228_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EH, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marin\u00f2 M (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382(4):341\u2013352","journal-title":"N Engl J Med"},{"issue":"1","key":"12228_CR24","doi-asserted-by":"publisher","first-page":"e001693","DOI":"10.1136\/bmjophth-2024-001693","volume":"9","author":"H-I Chiu","year":"2024","unstructured":"Chiu H-I, Shi-Bei W, Wu AY, Tsai C-C (2024) Endoplasmic reticulum protein TXNDC5 modulates thyroid eye disease TGF-\u03b21-induced myofibroblast transdifferentiation. BMJ Open Ophthalmol 9(1):e001693","journal-title":"BMJ Open Ophthalmol"},{"key":"12228_CR25","doi-asserted-by":"publisher","first-page":"111780","DOI":"10.1016\/j.mce.2022.111780","volume":"559","author":"B Xie","year":"2023","unstructured":"Xie B, Xiong W, Zhang F, Wang N, Luo Y, Chen Y, Cao J, Chen Z, Ma C, Chen H (2023) The miR-103a-3p\/TGFBR3 axis regulates TGF-\u03b2-induced orbital fibroblast activation and fibrosis in thyroid-eye disease. Mol Cell Endocrinol 559:111780","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"12228_CR26","first-page":"3645","volume":"31","author":"CA Street","year":"2011","unstructured":"Street CA, Bryan BA (2011) Rho kinase proteins\u2014pleiotropic modulators of cell survival and apoptosis. Anticancer Res 31(11):3645\u20133657","journal-title":"Anticancer Res"},{"key":"12228_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","volume":"64","author":"L Wei","year":"2016","unstructured":"Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J (2016) Novel insights into the roles of Rho kinase in cancer. Arch Immunol Ther Exp (Warsz) 64:259\u2013278","journal-title":"Arch Immunol Ther Exp (Warsz)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12228-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:47:20Z","timestamp":1782859640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12228-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12228"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12228-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research project was approved by the Ethics Committee of Shiraz University of Medical Sciences (approval number: IR.SUMS.MED.REC.1403.522) and conducted in accordance with the Declaration of Helsinki. Human tissues were obtained with written informed consent from the donors, as required by institutional and national ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not apllicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1051"}}